Quantcast

Latest Sanofi Stories

2014-10-20 08:30:43

TARRYTOWN, N.Y. and PARIS, Oct. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.

2014-10-17 08:26:00

Amgen Seeks Injunction Related to PCSK9 Inhibitor THOUSAND OAKS, Calif., Oct.

2014-10-15 12:36:16

Program Enables System Integrators, Managed Service Providers, and IT Consultants Ability to Offer White-Labeled Services to Their Customers ATLANTA, Oct.

2014-10-15 12:31:13

Sanofi, PBJ Capital, and a Major US Medical Device Company Provide Initial Financing for Breakthrough Medical Device Company CAMBRIDGE, Mass., Oct.

2014-10-13 08:26:58

- Stowe to be Joined by Leading Neurologists and People Living with the Disease for Live Events Nationwide - CAMBRIDGE, Mass., Oct.

2014-10-06 08:28:34

Unilife to be the sole provider of wearable injectors for all of Sanofi's applicable large dose volume drugs YORK, Pa., Oct.

2014-09-30 00:21:34

TARRYTOWN, N.Y. and PARIS, Sept. 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.

2014-09-29 12:20:45

CHICAGO, Sept. 29, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog.

2014-09-17 08:30:11

- Up to $200 Million Collaboration to Support Pioneering Science and New Treatments - PARIS and SOUTH SAN FRANCISCO, Calif., Sept.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related